OZEM vs. PJP ETF Comparison

Comparison of Roundhill GLP-1 & Weight Loss ETF (OZEM) to PowerShares Dynamic Pharmaceuticals (PJP)

OZEM

Roundhill GLP-1 & Weight Loss ETF

OZEM Description

OZEM targets the global weight management industry. The fund invests in companies involved in the development of GLP-1 and other weight loss drugs. GLP-1 agonists seek to aid in weight management by lowering blood sugar levels, reducing appetite, and promoting fullness. The portfolio consists of firms with GLP-1 and weight loss drugs that have been approved by or are currently undergoing Phase I, Phase II, and/or Phase III clinical trials of the US Food & Drug Administration (FDA), or any applicable food and drug regulator for non-US companies. The portfolio is constructed using a proprietary methodology, which selects companies with high levels of thematic relevance based on research of each companys public filings and disclosures. In addition, eligible securities must meet minimum market-cap and liquidity requirements. The actively managed fund, although rebalances portfolio weighting on at least a quarterly basis, may have a heavy concentration on a few names.

Grade (RS Rating)

Last Trade

$26.27

Average Daily Volume

82,294

Number of Holdings ^*

* may have additional holdings in another (foreign) market

PJP

PowerShares Dynamic Pharmaceuticals

PJP Description

The PowerShares Dynamic Pharmaceuticals Portfolio (Fund) is based on the Dynamic Pharmaceutical IntellidexSM Index (Intellidex Index). The Fund will normally invest at least 90% of its total assets in common stocks that comprise the Index. The Intellidex Index is designed to provide capital appreciation by thoroughly evaluating companies based on a variety of investment merit criteria, including: price momentum, earnings momentum, quality, management action, and value. The Underlying Intellidex Index is comprised of common stocks of 30 US pharmaceuticals companies. These are companies that are principally engaged in the research, development, manufacture, sale or distribution of pharmaceuticals and drugs of all types. The Fund and the Index are rebalanced and reconstituted quarterly in February, May, August and November.

Grade (RS Rating)

Last Trade

$82.31

Average Daily Volume

6,790

Number of Holdings ^*

* may have additional holdings in another (foreign) market

Performance

Period	OZEM	PJP
30 Days	4.45%	2.08%
60 Days		8.32%
90 Days		3.65%
12 Months		8.26%

2 Overlapping Holdings

	Symbol	Grade	Weight in OZEM	Weight in PJP	Overlap
	AMGN	B	4.2%	5.78%	4.2%
	LLY	B	21.39%	6.32%	6.32%

OZEM Overweight 5 Positions Relative to PJP

Symbol	Grade	Weight
NVO	A	20.52%
ALT	F	3.97%
TERN	C	3.32%
VKTX	D	3.27%
GPCR	C	3.14%

OZEM Underweight 20 Positions Relative to PJP

Symbol	Grade	Weight
ABBV	B	-6.31%
REGN	A	-6.19%
MRK	A	-5.97%
ABT	C	-5.91%
JNJ	C	-5.86%
PFE	C	-5.65%
GERN	C	-5.24%
JAZZ	F	-3.88%
UTHR	A	-3.86%
BIIB	C	-3.82%
INVA	B	-3.69%
PBH	C	-3.67%
GILD	C	-3.67%
ANIP	D	-3.57%
PRGO	F	-3.54%
AMPH	F	-3.48%
SUPN	D	-3.46%
PCRX	C	-3.38%
LGND	C	-3.36%
CORT	C	-3.31%

OZEM: Top Represented Industries & Keywords

Industries: Biotechnology Drug Manufacturers - Major

PJP: Top Represented Industries & Keywords

Industries: Biotechnology Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic Medical Devices Medical Distribution